396 Results

People

  1. Kris
    Kris
  2. Riely
    Riely
  3. Pao
    Pao
  4. Ladanyi
    Ladanyi
  5. O'Reilly
    O'Reilly
  6. Miller
    Miller
  7. Yu
    Yu
  8. Abou-Alfa
    Abou-Alfa
  9. Zakowski
    Zakowski
  10. Lacouture
    Lacouture

Groups

  1. Department of Medicine (237)
  2. Solid Tumor Oncology Division (203)
  3. Thoracic Oncology (97)
  4. GSK Faculty (87)
  5. Gastrointestinal Oncology Service (74)
  6. Tow Center for Developmental Oncology (TCDO) (70)
  7. Human Oncology and Pathogenesis Program (65)
  8. Department of Pathology and Laboratory Medicine (64)
  9. Center for Pancreatic Cancer Research (43)
  10. Surgery (43)
  1. "erlotinib"
Formats
  1. Journal Article (362)
  2. Review (16)
  3. Meeting Abstract (7)
  4. Conference Paper (4)
  5. Book Section (2)
  6. Editorial (2)
  7. Guidelines (2)
  8. Correspondence (1)
Groups
  1. Department of Medicine (237)
  2. Solid Tumor Oncology Division (203)
  3. Thoracic Oncology (97)
  4. GSK Faculty (87)
  5. Gastrointestinal Oncology Service (74)
  6. Tow Center for Developmental Oncology (TCDO) (70)

More Groups

People
  1. Mark Kris (53)
  2. Gregory Riely (51)
  3. Vincent Miller (45)
  4. William Pao (42)
  5. Marc Ladanyi (41)
  6. Eileen O'Reilly (28)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (5)
  4. 2022 (7)
  5. 2021 (6)
  6. 2020 (7)

More Years

Publications
  1. Clinical Cancer Research (35)
  2. Journal of Thoracic Oncology (33)
  3. Journal of Clinical Oncology (23)
  4. Cancer (12)
  5. Journal of the National Comprehensive Cancer Network (11)
  6. Supportive Care in Cancer (8)

More Publications

Publishers
  1. Elsevier Inc. (77)
  2. American Association for Cancer Research (45)
  3. American Society of Clinical Oncology (26)
  4. Oxford University Press (21)
  5. Springer (21)
  6. Wiley Blackwell (21)

More Publishers

Results (396)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Indication-specific pricing for cancer drugs
    Journal Article

    Bach, P. B.
    JAMA - Journal of the American Medical Association (2014)

    Fulltext@MSK | Save
  • Pharmacogenomic modeling of circulating tumor and invasive cells for prediction of chemotherapy response and resistance in pancreatic cancer
    Journal Article

    Yu, K. H.; Ricigliano, M.; Hidalgo, M.; Abou-Alfa, G. K.; Lowery, M. A.; Saltz, L. B.; Crotty, J. F.; Gary, K.; Cooper, B.; Lapidus, R.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • The search for novel therapeutic strategies in the treatment of recurrent glioblastoma multiforme
    Journal Article

    Bambury, R. M.; Morris, P. G.
    Expert Review of Anticancer Therapy (2014)

    Fulltext@MSK | Save
  • Ipilimumab in patients with cancer and the management of dermatologic adverse events
    Journal Article

    Lacouture, M. E.; Wolchok, J. D.; Yosipovitch, G.; Kähler, K. C.; Busam, K. J.; Hauschild, A.
    Journal of the American Academy of Dermatology (2014)

    Fulltext@MSK | Save
  • Small-cell lung cancers in patients who never smoked cigarettes
    Journal Article

    Varghese, A. M.; Zakowski, M. F.; Yu, H. A.; Won, H. H.; Riely, G. J.; Krug, L. M.; Kris, M. G.; Rekhtman, N.; Ladanyi, M.; Wang, L.; more...
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer
    Journal Article

    Maitland, M. L.; Levine, M. R.; Lacouture, M. E.; Wroblewski, K. E.; Chung, C. H.; Gordon, I. O.; Szeto, L.; Ratko, G.; Soltani, K.; Kozloff, M. F.; more...
    BMC Cancer (2014)

    Fulltext@MSK | Save
  • A phase II study of HSP90 inhibitor AUY922 and erlotinib (E) in patients (PTS) with EGFR-mutant lung cancer and acquired resistance (AR) to EGFR tyrosine kinase inhibitors (EGFR TKIS)
    Meeting Abstract

    Yu, H. A.; Johnson, M. L.; Urman, A.; Rademaker, A.; Hart, E.; Weitner, B. B.; Patel, J. D.; Kris, M.; Riely, G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Gerber, N. K.; Yamada, Y.; Shi, W. J.; Zhang, Z. G.; Riely, G.; Beal, K.; Yu, H. A.; Chan, T. A.; Rimner, A.; Wu, A. J.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Integrated genomic analysis by whole exome and transcriptome sequencing of tumor samples from egfr-mutant non-small-cell lung cancer (NSCLC) patients with acquired resistance to erlotinib
    Meeting Abstract

    Bivona, T.; Gianikopoulos, P.; Costa, C.; Karachaliou, N.; St John, J.; Wilkerson, M.; Cauhlin, A. F.; Westesson, O.; Boley, N.; Hahner, N.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A genomics-based classification of human lung tumors
    Journal Article

    The Clinical Lung Cancer Genome Project (CLCGP); Network Genomic Medicine (NGM)
    Science Translational Medicine (2013)

    Fulltext@MSK | Save